
Pear Therapeutics
Founded Year
2013Stage
Asset Sale | AssetsPurchasedTotal Raised
$334.94MRevenue
$0000About Pear Therapeutics
Pear Therapeutics focuses on developing and commercializing software-based medicines, known as prescription digital therapeutics (PDTs), within the healthcare sector. The company offers clinically validated software-based therapeutics designed to provide better outcomes for patients, engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear Therapeutics primarily serves the healthcare industry, focusing on patients with substance use disorder, opioid use disorder, and chronic insomnia. It was founded in 2013 and is based in Boston, Massachusetts. In April 2023 Pear Therapeutics filed for bankruptcy.
Loading...
Loading...
Research containing Pear Therapeutics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Pear Therapeutics in 3 CB Insights research briefs, most recently on Jan 25, 2024.

Jan 25, 2024 report
State of Digital Health 2023 ReportExpert Collections containing Pear Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pear Therapeutics is included in 3 Expert Collections, including Digital Health 50.
Digital Health 50
300 items
The most promising digital health startups transforming the healthcare industry
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Pear Therapeutics Patents
Pear Therapeutics has filed 14 patents.
The 3 most popular patent topics include:
- cognitive behavioral therapy
- monoclonal antibodies
- psychiatric diagnosis

Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/11/2023 | 2/27/2024 | Data security, Monoclonal antibodies, Cryptographic hash functions, Health informatics, Medical terminology | Grant |
Application Date | 4/11/2023 |
|---|---|
Grant Date | 2/27/2024 |
Title | |
Related Topics | Data security, Monoclonal antibodies, Cryptographic hash functions, Health informatics, Medical terminology |
Status | Grant |
Latest Pear Therapeutics News
Oct 24, 2025
HLTH Conference 2025: Seven Key Announcements Reshaping Healthcare Innovation Las Vegas, NV – The HLTH conference, a cornerstone event for healthcare innovation, concluded this week with a flurry of announcements poised to significantly impact the industry. From groundbreaking partnerships to substantial funding rounds and the unveiling of cutting-edge products, the event showcased the dynamism and forward momentum of the healthcare sector. This report details seven of the most noteworthy developments from HLTH 2025, offering a glimpse into the future of healthcare delivery and technology. The healthcare landscape is undergoing a rapid transformation, driven by technological advancements and a growing emphasis on patient-centric care. The HLTH conference serves as a vital platform for stakeholders to collaborate, share insights, and accelerate the adoption of innovative solutions. But what specific breakthroughs emerged this year? Let’s delve into the details. The Rise of AI-Powered Personalized Medicine Several announcements centered around the integration of artificial intelligence (AI) into personalized medicine. One prominent example is the partnership between BioPredictive and Genomix, aiming to leverage AI algorithms to analyze genomic data and predict individual responses to various treatments. This promises to move healthcare away from a one-size-fits-all approach towards more targeted and effective interventions. Funding Boost for Remote Patient Monitoring Remote patient monitoring (RPM) continues to gain traction, fueled by the need for accessible and cost-effective healthcare solutions. At HLTH, CareSignal secured $45 million in Series B funding, led by General Catalyst, to expand its RPM platform for chronic condition management. This investment underscores the growing confidence in RPM’s ability to improve patient outcomes and reduce hospital readmissions. New Digital Therapeutics for Mental Health Addressing the growing mental health crisis, Pear Therapeutics unveiled its latest digital therapeutic, a mobile app designed to provide cognitive behavioral therapy (CBT) for anxiety disorders. This non-pharmacological approach offers a convenient and accessible alternative to traditional mental healthcare, potentially reaching underserved populations. Interoperability Advancements with FHIR Standards Improving data interoperability remains a critical challenge in healthcare. HL7 International announced significant progress in the adoption of FHIR (Fast Healthcare Interoperability Resources) standards, enabling seamless data exchange between different electronic health record (EHR) systems. This advancement is crucial for facilitating coordinated care and empowering patients with access to their health information. Partnership to Tackle Healthcare Cybersecurity Threats With the increasing prevalence of cyberattacks targeting healthcare organizations, cybersecurity has become a paramount concern. Palo Alto Networks and CrowdStrike announced a strategic partnership to provide comprehensive cybersecurity solutions tailored to the unique needs of the healthcare industry. This collaboration aims to protect sensitive patient data and ensure the continuity of care. Expansion of Value-Based Care Models The shift towards value-based care, which rewards providers for delivering high-quality, cost-effective care, is gaining momentum. Oak Street Health announced plans to expand its network of value-based primary care centers to five new states, bringing its innovative care model to a wider population. This expansion reflects the growing recognition of the benefits of value-based care for both patients and providers. Blockchain Technology for Supply Chain Integrity Ensuring the integrity of the pharmaceutical supply chain is essential for patient safety. Chronicled, a blockchain-based supply chain platform, announced a new partnership with several major pharmaceutical manufacturers to track and trace medications from origin to point of sale. This technology helps to combat counterfeit drugs and protect patients from harm. What role will blockchain play in securing the future of healthcare supply chains? These announcements represent just a fraction of the innovation showcased at HLTH 2025. The conference highlighted the transformative potential of technology to address some of the most pressing challenges facing the healthcare industry. But how will these advancements translate into tangible benefits for patients and providers in the years to come? Frequently Asked Questions About HLTH 2025 Q: What is the primary focus of the HLTH conference? A: The HLTH conference primarily focuses on fostering innovation and collaboration within the healthcare industry, bringing together stakeholders to discuss and showcase the latest advancements in technology, policy, and care delivery. Q: How does AI impact personalized medicine, as discussed at HLTH 2025? A: AI algorithms are being used to analyze genomic data and predict individual responses to treatments, enabling a more targeted and effective approach to healthcare, moving away from generalized treatment plans. Q: What role does remote patient monitoring play in modern healthcare? A: Remote patient monitoring provides accessible and cost-effective healthcare solutions, particularly for chronic condition management, improving patient outcomes and reducing hospital readmissions. Q: Why is interoperability important in the healthcare sector? A: Interoperability, facilitated by standards like FHIR, enables seamless data exchange between EHR systems, improving coordinated care and empowering patients with access to their health information. Q: What are the benefits of value-based care models? A: Value-based care rewards providers for delivering high-quality, cost-effective care, leading to improved patient outcomes and a more sustainable healthcare system. Q: How can blockchain technology enhance pharmaceutical supply chain security? A: Blockchain provides a secure and transparent platform for tracking and tracing medications, combating counterfeit drugs and protecting patients from harm. The announcements from HLTH 2025 signal a period of rapid change and innovation in healthcare. As these technologies and models mature, they have the potential to transform the way care is delivered and improve the health and well-being of individuals around the world. Disclaimer: This article provides general information about healthcare trends and should not be considered medical advice. Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment. Share this article with your network to spark a conversation about the future of healthcare! What announcement from HLTH 2025 excites you the most, and why? Leave a comment below and let us know your thoughts. Share this:
Pear Therapeutics Frequently Asked Questions (FAQ)
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013.
Where is Pear Therapeutics's headquarters?
Pear Therapeutics's headquarters is located at 200 State Street, Boston.
What is Pear Therapeutics's latest funding round?
Pear Therapeutics's latest funding round is Asset Sale.
How much did Pear Therapeutics raise?
Pear Therapeutics raised a total of $334.94M.
Who are the investors of Pear Therapeutics?
Investors of Pear Therapeutics include WELT, Click Therapeutics, Nox Health, Harvest Bio, SoftBank and 20 more.
Who are Pear Therapeutics's competitors?
Competitors of Pear Therapeutics include Click Therapeutics, Cara Care, Lionrock, Akili Interactive, Valera Health and 7 more.
Loading...
Compare Pear Therapeutics to Competitors

Lyra Health operates in workforce mental health care within the health benefits industry. The company provides a digital platform that connects employees to mental health providers and tools, utilizing artificial intelligence (AI) for provider matching and offering evidence-based support. Lyra Health serves employers seeking to provide mental health benefits and support employee well-being. It was founded in 2015 and is based in Burlingame, California.

Monument is an online platform that specializes in alcohol treatment and recovery services. The company offers a range of services, including virtual support groups, therapy, and medication management, to assist individuals in reducing or stopping alcohol consumption. Monument's treatment options are accessible online, providing a flexible and supportive environment for those seeking help with alcohol dependence. It was founded in 2018 and is based in New York, New York.

Mobio Interactive specializes in digital therapeutics and remote patient monitoring within the mental healthcare sector. The company offers an AI-native mobile platform that uses proprietary technologies to measure and treat mental health conditions, providing personalized therapy based on objective biomarkers. The platform primarily serves health systems, pharmaceutical companies, and insurance payors. It was founded in 2015 and is based in Singapore.

Pivot is a digital health company that focuses on tobacco cessation and behavioral change within the healthcare sector. The company offers a comprehensive suite of solutions, including digital programs, mobile applications, and personalized coaching designed to help individuals quit tobacco and improve their well-being. Pivot primarily serves employers, health plans, consultants, and brokers looking to integrate wellness solutions into their offerings. It was founded in 2015 and is based in San Carlos, California.

2Morrow focuses on digital health and well-being in the healthcare industry. The company offers behavioral health and wellness programs that aim to help individuals make meaningful changes toward their personal goals and values. The company's programs are delivered through a digital platform, accessible via a smartphone or website, and are used by a variety of entities, including large employers, states, and health plans. It was founded in 2012 and is based in Kirkland, Washington.

MediSafe operates as a medication management platform in the healthcare technology sector. The company offers a solution that enables patients to manage their health through tools such as appointment scheduling, symptom tracking, and care team connectivity. MediSafe's platform integrates technology with behavioral science to provide healthcare guidance. It was founded in 2012 and is based in Needham, Massachusetts.
Loading...

